Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
122 studies found for:    Chorea
Show Display Options
Rank Status Study
21 Completed An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196
Condition: Huntington's Disease
Interventions: Drug: SEN0014196 (Low Dose);   Drug: SEN0014196 (High Dose);   Drug: Placebo
22 Withdrawn Treating Sleep/Wake Cycle Disturbances in Basal Ganglia Disorders With Ramelteon
Conditions: Huntington's Disease;   Parkinson's Disease;   Dementia With Lewy Bodies;   Sleep Disorders;   Circadian Dysregulation
Interventions: Drug: Ramelteon;   Drug: Placebo
23 Recruiting Neuroleptic and Huntington Disease Comparison of : Olanzapine, la Tetrabenazine and Tiapride
Condition: Huntington Disease
Interventions: Drug: Olanzapine;   Drug: Xenazine;   Drug: Tiapridal
24 Not yet recruiting PINS Stimulator System for Deep Brain Stimulation in Huntington's Disease
Condition: Huntington's Disease
Intervention: Device: Deep Brain Stimulation
25 Not yet recruiting Brain Stimulation in Movement Disorders
Conditions: Huntington's Disease;   Tourette Syndrome
Intervention: Other: Transcranial direct current stimulation
26 Active, not recruiting Open-label Extension Study of Pridopidine (ACR16) in the Symptomatic Treatment of Huntington Disease
Condition: Huntington Disease
Intervention: Drug: pridopidine
27 Completed TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease
Condition: Huntington Disease
Intervention: Drug: Ethyl-EPA  (Miraxion™)
28 Terminated Compassionate Use of Tetrabenazine in the Treatment of Abnormal Movements
Condition: Hyperkinetic Movement Disorders
Intervention: Drug: tetrabenazine
29 Completed Famotidine for Levodopa-induced Dyskinesia in PD
Condition: Dyskinesia
Intervention: Drug: Famotidine
30 Completed Different Dyskinesias in Parkinson's Disease and Their Relation to Levodopa Pharmacokinetics
Conditions: Parkinson Disease;   Dyskinesias
Intervention: Drug: levodopa/carbidopa
31 Completed Comparative 2-D Tumor Analysis in Familial Gliomas
Condition: Malignant Glioma
Intervention:
32 Recruiting I2PETHV - Imidazoline2 Binding Site in Healthy Volunteers
Conditions: Healthy Volunteers;   Alzheimer Disease;   Molecular Imaging
Interventions: Radiation: [11C]BU99008;   Drug: Idazoxan;   Drug: Isocarboxazid
33 Not yet recruiting Finding Genes With NGS Techniques in Whom Mutations Cause Neurological Diseases
Condition: Neurological Diseases
Intervention: Genetic: Genetic testing
34 Unknown  Dopamine Treatment in Children With Cerebral Palsy With Dystonia- A Double Blind Controlled Study
Condition: Dystonic Cerebral Palsy
Interventions: Drug: L- DOPA;   Drug: placebo
35 Completed Preventive Measures for Childhood-Onset Obsessive-Compulsive Disorder and Tic Disorders (PANDAS Subgroup)
Conditions: Mental Disorder Diagnosed in Childhood;   Obsessive Compulsive Disorder;   Streptococcal Infection;   Tic Disorder
Intervention: Drug: Penicillin or Placebo
36 Unknown  Exploring Hypertonia in Children With Cerebral Palsy
Condition: Cerebral Palsy.
Intervention: Other: No intervention applicable
37 Completed A Study In Healthy Volunteers To Estimate The Pharmacokinetics Of Four Modified-Release Formulations Of Dimebon (Latrepirdine)
Conditions: Alzheimer's Disease;   Huntington Disease
Interventions: Drug: Dimebon IR Tablet;   Drug: Dimebon MR1;   Drug: Dimebon MR2;   Drug: Dimebon MR3;   Drug: Dimebon MR4
38 Recruiting Neurobiological Predictors of Huntington's Disease (PREDICT-HD)
Condition: Huntington Disease
Intervention:
39 Completed Safety Study of the Novel Drug Dimebon to Treat Patients With Huntington's Disease
Condition: Huntington's Disease
Intervention: Drug: Dimebon
40 Completed A Trial of Memantine as Symptomatic Treatment for Early Huntington Disease
Condition: Huntington Disease
Interventions: Drug: Memantine;   Other: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years